Phospho-BAD BH3 mimicry protects β cells and restores functional β cell mass in diabetes

Cell Reports

Volumn 10, Issue 4, 2015, Pages 497-504

  Ljubicic, Sanda ^a,b   Polak, Klaudia ^a   Fu, Accalia ^a,b   Wiwczar, Jessica ^a   Szlyk, Benjamin ^a   Chang, Yigang ^c   Alvarez Perez, Juan C ^d   Bird, Gregory H ^a   Walensky, Loren D ^a   Garcia Ocaña, Adolfo ^d   Danial, Nika N ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BH3 PROTEIN; GLUCOKINASE; INSULIN; PROTEIN BAD; PROTEIN BCL 2;

ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ASSAY; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL CULTURE; CELL LINE; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHYSIOLOGY; RAT;

MUS;

ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCOKINASE; IN VITRO TECHNIQUES; INSULIN-SECRETING CELLS; MICE; RATS;

EID: 84922768047     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.056     Document Type: Article

References (30)

1. Bedoya F.J., Salguero-Aranda C., Cahuana G.M., Tapia-Limonchi R., Soria B., Tejedo J.R. Regulation of pancreatic β-cell survival by nitric oxide: clinical relevance. Islets 2012, 4:108-118.
2. Bensellam M., Laybutt D.R., Jonas J.C. The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Mol. Cell. Endocrinol. 2012, 364:1-27.
3. Biarnés M., Montolio M., Nacher V., Raurell M., Soler J., Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002, 51:66-72.
4. Claiborn K.C., Stoffers D.A. Toward a cell-based cure for diabetes: advances in production and transplant of beta cells. Mt. Sinai J. Med. 2008, 75:362-371.
5. Danial N.N. BAD: undertaker by night, candyman by day. Oncogene 2008, 27(Suppl 1):S53-S70.
6. Danial N.N., Walensky L.D., Zhang C.Y., Choi C.S., Fisher J.K., Molina A.J., Datta S.R., Pitter K.L., Bird G.H., Wikstrom J.D., et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 2008, 14:144-153.
7. Danial N.N., Gimenez-Cassina A., Tondera D. Homeostatic functions of BCL-2 proteins beyond apoptosis. Adv. Exp. Med. Biol. 2010, 687:1-32.
8. Donath M.Y., Størling J., Berchtold L.A., Billestrup N., Mandrup-Poulsen T. Cytokines and beta-cell biology: from concept to clinical translation. Endocr. Rev. 2008, 29:334-350.
9. Eizirik D.L., Miani M., Cardozo A.K. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 2013, 56:234-241.
10. Elghazi L., Balcazar N., Blandino-Rosano M., Cras-Méneur C., Fatrai S., Gould A.P., Chi M.M., Moley K.H., Bernal-Mizrachi E. Decreased IRS signaling impairs beta-cell cycle progression and survival in transgenic mice overexpressing S6K in beta-cells. Diabetes 2010, 59:2390-2399.
11. Giménez-Cassina A., Garcia-Haro L., Choi C.S., Osundiji M.A., Lane E.A., Huang H., Yildirim M.A., Szlyk B., Fisher J.K., Polak K., et al. Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab. 2014, 19:272-284.
12. Grimsby J., Sarabu R., Corbett W.L., Haynes N.E., Bizzarro F.T., Coffey J.W., Guertin K.R., Hilliard D.W., Kester R.F., Mahaney P.E., et al. Allosteric activators of glucokinase: potential role in diabetes therapy. Science 2003, 301:370-373.
13. Halban P.A., German M.S., Kahn S.E., Weir G.C. Current status of islet cell replacement and regeneration therapy. J.Clin. Endocrinol. Metab. 2010, 95:1034-1043.
14. Hebrok M. Generating β cells from stem cells-the story so far. Cold Spring Harb. Perspect. Med. 2012, 2:a007674.
15. Levitt H.E., Cyphert T.J., Pascoe J.L., Hollern D.A., Abraham N., Lundell R.J., Rosa T., Romano L.C., Zou B., O'Donnell C.P., et al. Glucose stimulates human beta cell replication invivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia 2011, 54:572-582.
16. Liu S., Okada T., Assmann A., Soto J., Liew C.W., Bugger H., Shirihai O.S., Abel E.D., Kulkarni R.N. Insulin signaling regulates mitochondrial function in pancreatic beta-cells. PLoS ONE 2009, 4:e7983.
17. Luciani D.S., White S.A., Widenmaier S.B., Saran V.V., Taghizadeh F., Hu X., Allard M.F., Johnson J.D. Bcl-2 and Bcl-xL suppress glucose signaling in pancreatic β-cells. Diabetes 2013, 62:170-182.
18. Mastrandrea L.D., Sessanna S.M., Del Toro A., Laychock S.G. ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets. J.Lipid Res. 2010, 51:2171-2180.
19. Matschinsky F.M. Assessing the potential of glucokinase activators in diabetes therapy. Nat. Rev. Drug Discov. 2009, 8:399-416.
20. McKenzie M.D., Jamieson E., Jansen E.S., Scott C.L., Huang D.C., Bouillet P., Allison J., Kay T.W., Strasser A., Thomas H.E. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 2010, 59:644-652.
21. Montaña E., Bonner-Weir S., Weir G.C. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J.Clin. Invest. 1993, 91:780-787.
22. Pagliuca F.W., Melton D.A. How to make a functional β-cell. Development 2013, 140:2472-2483.
23. Plesner A., Verchere C.B. Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation. J.Transplant. 2011, 2011:979527.
24. Porat S., Weinberg-Corem N., Tornovsky-Babaey S., Schyr-Ben-Haroush R., Hija A., Stolovich-Rain M., Dadon D., Granot Z., Ben-Hur V., White P., et al. Control of pancreatic β cell regeneration by glucose metabolism. Cell Metab. 2011, 13:440-449.
25. Prentki M., Matschinsky F.M., Madiraju S.R. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013, 18:162-185.
26. Sjöholm A. Glucose stimulates islet beta-cell mitogenesis through GTP-binding proteins and by protein kinase C-dependent mechanisms. Diabetes 1997, 46:1141-1147.
27. Szlyk B., Braun C.R., Ljubicic S., Patton E., Bird G.H., Osundiji M.A., Matschinsky F.M., Walensky L.D., Danial N.N. A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators. Nat. Struct. Mol. Biol. 2014, 21:36-42.
28. Terauchi Y., Takamoto I., Kubota N., Matsui J., Suzuki R., Komeda K., Hara A., Toyoda Y., Miwa I., Aizawa S., et al. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J.Clin. Invest. 2007, 117:246-257.
29. Wei P., Shi M., Barnum S., Cho H., Carlson T., Fraser J.D. Effects of glucokinase activators GKA50 and LY2121260 on proliferation and apoptosis in pancreatic INS-1 beta cells. Diabetologia 2009, 52:2142-2150.
30. Zhou Y.P., Pena J.C., Roe M.W., Mittal A., Levisetti M., Baldwin A.C., Pugh W., Ostrega D., Ahmed N., Bindokas V.P., et al. Overexpression of Bcl-x(L) in beta-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2000, 278:E340-E351.